Cargando…
Mesenchymal Stem Cells Ameliorate Hyperglycemia in Type I Diabetic Developing Male Rats
One of the most promising treatments for diabetes mellitus (DM) is stem cell therapy. This study is aimed at elucidating the antidiabetic effect of mesenchymal stem cells (MSCs) on streptozotocin- (STZ-) induced DM in developing male rats. Twenty-four male albino rats (4 weeks old) were divided into...
Autores principales: | Yousef, Hany N., Sakr, Samia M., Sabry, Sahar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020910/ https://www.ncbi.nlm.nih.gov/pubmed/35463813 http://dx.doi.org/10.1155/2022/7556278 |
Ejemplares similares
-
Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats
por: Niu, Ho-Shan, et al.
Publicado: (2016) -
Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012) -
Therapeutic efficacy of differentiated versus undifferentiated mesenchymal stem cells in experimental type I diabetes in rat
por: Wassef, M.A., et al.
Publicado: (2016) -
Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats
por: Liao, Naishun, et al.
Publicado: (2017) -
Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy
por: Zhu, Wuzheng, et al.
Publicado: (2018)